RxDoctor Payments Data

Jamie Carter

Psychiatric/Mental Health · Springfield, MONPI 1134870173

Payments from drug & device makers

$4,568in general payments, 2019–2025

Across 239 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$751
  • Axsome Therapeutics, Inc.$513
  • Alkermes, Inc.$486
  • Teva Pharmaceuticals USA, Inc.$469
  • Johnson & Johnson$392
  • Indivior Inc.$369
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$4,47198%
  • Education$972%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,568 in reported general payments places this provider in the 85th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Medicare billing

Part B allowed, 2024
$3,874
Medicare patients
11
Services billed
86

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine43$279,589
Invega SustennaPaliperidone Palmitate29$108,637
CaplytaLumateperone Tosylate31$67,304
RexultiBrexpiprazole36$58,027
LybalviOlanzapine/Samidorphan Malate24$39,868
NuedextaDextromethorphan Hbr/Quinidine25$38,240
Abilify MaintenaAripiprazole11$32,807
VraylarCariprazine Hcl12$18,663
TrintellixVortioxetine Hydrobromide25$13,229
Lurasidone Hcl41$11,249
Aripiprazole30$6,255
Chlorpromazine Hcl17$5,214
Divalproex Sodium ErDivalproex Sodium26$2,671
Clomipramine Hcl12$2,215
Clozapine25$1,652

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$469$279,58943 claims
Johnson & JohnsonInvega Sustenna$392$108,63729 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$348$90,83447 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$262$67,30431 claims
Alkermes, Inc.Lybalvi$486$39,86824 claims
Avanir Pharmaceuticals, Inc.Nuedexta$64$38,24025 claims
AbbVieVraylar$751$18,66312 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$122$13,22925 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 565 psychiatric/mental health providers in Missouri.

Other psychiatric/mental health in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →